JAZZ Jazz Pharmaceuticals
Jazz Pharmaceuticals earnings company data as of 4:45 AM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 1.97 | — | — |
| Rev | $1.21B | — | — |
Insider trades
Open-market buys and sales by JAZZ's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $35.3M sold by 8 insiders outside a trading plan
- $33.2M sold by 5 insiders under 10b5-1 plans
-
Renee D Gala CEOPlanned sale$473K 2,000 shares at $236.40 1.4% of stakeTraded Oct 6 Filed Oct 7
-
Bruce C Cozadd DirectorPlanned sale$1.4M 6,000 shares at $230.33 1.7% of stakeTraded Oct 1 Filed Oct 5
-
Neena M Patil EVP & Chief Legal OfficerPlanned sale$289K 1,200 shares at $240.94 2.5% of stakeTraded Sep 10 Filed Sep 14
-
Renee D Gala CEOPlanned sale$486K 2,000 shares at $243.03 1.4% of stakeTraded Sep 8 Filed Sep 10
-
Bruce C Cozadd DirectorPlanned sale$1.5M 6,000 shares at $250.13 1.7% of stakeTraded Sep 1 Filed Sep 2
-
Robert Iannone EVP, Global Head of R&D & CMOPlanned sale$19.2M 76,921 shares at $249.70 54% of stakeTraded Aug 27 Filed Aug 31
-
Bruce C Cozadd DirectorPlanned sale$1.5M 6,000 shares at $252.98 1.6% of stakeTraded Aug 3 Filed Aug 5
-
Bruce C Cozadd DirectorPlanned sale$1.4M 6,000 shares at $240.47 1.6% of stakeTraded Jul 1 Filed Jul 6
-
Mark Douglas Smith DirectorPlanned sale$267K 1,157 shares at $230.55 11% of stakeTraded Jun 15 Filed Jun 17
-
Neena M Patil EVP & Chief Legal OfficerPlanned sale$278K 1,200 shares at $231.83 2.3% of stakeTraded Jun 10 Filed Jun 12
-
Bruce C Cozadd DirectorPlanned sale$1.4M 6,000 shares at $235.12 1.6% of stakeTraded Jun 1 Filed Jun 3
-
Samantha Pearce EVP, Chief Commercial OfficerSale$1.6M 6,907 shares at $235.41 12% of stakeTraded May 28 Filed Jun 1
-
Neena M Patil EVP & Chief Legal OfficerPlanned sale$282K 1,192 shares at $236.97 2.2% of stakeTraded May 28 Filed Jun 1
-
Heather Ann McSharry DirectorSale$482K 2,000 shares at $241.00 9.8% of stakeTraded May 22 Filed May 27
-
Rick E Winningham DirectorSale$662K 2,741 shares at $241.57 22% of stakeTraded May 22 Filed May 27
Also filed in the last 12 months, not counted as buying or selling: 45 share withholdings for taxes, 27 stock grants, 17 option exercises, 2 sales back to the company, 2 sales to cover taxes, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 10 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.